Clinical Trial Support: Point Of Need vs. Traditional Solutions

Examine the limitations of traditional fixed-location ophthalmic trial sites, which often face operational challenges such as scheduling delays, inconsistent technician training, and increased patient burden, particularly for those with mobility issues. In contrast, the mobile assessment model offered by 20/20 Onsite presents a transformative solution for clinical trials. By delivering services directly to patients, this approach enhances scheduling adherence and reduces logistical barriers, making it especially advantageous for early-phase trials that demand rapid adaptability and high patient throughput.
The 20/20 Onsite model streamlines operations, scales resources efficiently, and leverages specialized expertise in trial logistics and protocol design. As a result, it significantly improves patient retention and satisfaction while ensuring high-quality data collection and compliance with trial protocols. Ultimately, collaboration with 20/20 Onsite enables sponsors, CROs, and trial sites to achieve a strategic balance between operational flexibility and methodological rigor.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.